Abbreviation |
Meaning |
AA |
arachidonic acid |
adrenic acid |
cis ω6 polyunsaturated (22:4) or 7,10,13,16-docosatetraenoic acid |
CHD |
coronary heart disease |
CVD |
cardiovascular disease |
DGLA |
dihomo gamma linolenic |
DHA |
docosahexaenoic acid |
DPA-n6 |
docosapentaenoic n-6 acid |
EPA |
eicosapentaenoic acid |
FA |
fatty acid |
FDR |
False Discovery Rate |
WHS |
Women’s Health Study |
GC |
gas chromatography |
RBC |
gas chromatography-mass spectrometry with flame ionization decoupling in red blood cells |
LC |
liquid chromatography |
LCMS |
high-throughput liquid chromatography-mass spectrometry of circulating free FAs, oxylipins and bioactive lipids from plasma |
plasma PL |
LCMS2 plasma phospholipid assay |
MI |
myocardial infarction |
MS |
mass spectrometry |
n-3 |
omega-3 |
n-6 |
omega-6 |
o3:6i |
omega-3 to omega-6 index (=[EPA + DHA]/AA) |
o3i |
omega-3 index (=EPA + DHA) |
SD |
standard deviation |
VITAL |
Vitamin D and Omega-3 Trial |